Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TScan Therapeutics (TCRX) Interest Coverage Ratio (2022 - 2025)

TScan Therapeutics (TCRX) has disclosed Interest Coverage Ratio for 4 consecutive years, with 33.99 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 27.42% to 33.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 49.05 through Dec 2025, down 32.9% year-over-year, with the annual reading at 49.05 for FY2025, 32.9% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 33.99 at TScan Therapeutics, up from 53.01 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 19.13 in Q4 2022, with the low at 82.48 in Q3 2022.
  • Average Interest Coverage Ratio over 4 years is 39.07, with a median of 34.02 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 69.44% in 2023, then plummeted 86.81% in 2024.
  • Over 4 years, Interest Coverage Ratio stood at 19.13 in 2022, then tumbled by 31.05% to 25.07 in 2023, then crashed by 86.81% to 46.83 in 2024, then rose by 27.42% to 33.99 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 33.99, 53.01, and 56.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.